In this study, a significant causal relationship between serum ApoA-1 levels and insomnia in the European population was found, with each SD increase in ApoA-1 levels reducing the risk of insomnia by 24.54%, suggesting that serum ApoA-1 levels are also a protective factor for insomnia. The gene discussed is APOA1; the disease is insomnia.